112 related articles for article (PubMed ID: 37622228)
1. Efficient fabrication of thermo-stable dissolving microneedle arrays for intradermal delivery of influenza whole inactivated virus vaccine.
Lee J; Beukema M; Zaplatynska OA; O'Mahony C; Hinrichs WLJ; Huckriede ALW; Bouwstra JA; van der Maaden K
Biomater Sci; 2023 Oct; 11(20):6790-6800. PubMed ID: 37622228
[TBL] [Abstract][Full Text] [Related]
2. Intradermal Administration of Influenza Vaccine with Trehalose and Pullulan-Based Dissolving Microneedle Arrays.
Tian Y; Lee J; van der Maaden K; Bhide Y; de Vries-Idema JJ; Akkerman R; O'Mahony C; Jiskoot W; Frijlink HW; Huckriede ALW; Hinrichs WLJ; Bouwstra JA; Beukema M
J Pharm Sci; 2022 Apr; 111(4):1070-1080. PubMed ID: 35122832
[TBL] [Abstract][Full Text] [Related]
3. Engineering of an automated nano-droplet dispensing system for fabrication of antigen-loaded dissolving microneedle arrays.
Lee J; van der Maaden K; Gooris G; O'Mahony C; Jiskoot W; Bouwstra J
Int J Pharm; 2021 May; 600():120473. PubMed ID: 33737094
[TBL] [Abstract][Full Text] [Related]
4. Dissolving Microneedle Arrays with Optimized Needle Geometry for Transcutaneous Immunization.
Li Y; Hu X; Dong Z; Chen Y; Zhao W; Wang Y; Zhang L; Chen M; Wu C; Wang Q
Eur J Pharm Sci; 2020 Aug; 151():105361. PubMed ID: 32422374
[TBL] [Abstract][Full Text] [Related]
5. Skin-targeted delivery of extracellular vesicle-encapsulated curcumin using dissolvable microneedle arrays.
Yerneni SS; Yalcintas EP; Smith JD; Averick S; Campbell PG; Ozdoganlar OB
Acta Biomater; 2022 Sep; 149():198-212. PubMed ID: 35809788
[TBL] [Abstract][Full Text] [Related]
6. Investigation on fabrication process of dissolving microneedle arrays to improve effective needle drug distribution.
Wang Q; Yao G; Dong P; Gong Z; Li G; Zhang K; Wu C
Eur J Pharm Sci; 2015 Jan; 66():148-56. PubMed ID: 25446513
[TBL] [Abstract][Full Text] [Related]
7. Development of an Orodispersible Film Containing Stabilized Influenza Vaccine.
Tian Y; Bhide YC; Woerdenbag HJ; Huckriede ALW; Frijlink HW; Hinrichs WLJ; Visser JC
Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32182676
[TBL] [Abstract][Full Text] [Related]
8. Chemical imaging analysis of active pharmaceutical ingredient in dissolving microneedle arrays by Raman spectroscopy.
Ando D; Miyazaki T; Yamamoto E; Koide T; Izutsu KI
Drug Deliv Transl Res; 2022 Feb; 12(2):426-434. PubMed ID: 34431066
[TBL] [Abstract][Full Text] [Related]
9. Transdermal Delivery of Salmon Calcitonin Using a Dissolving Microneedle Array: Characterization, Stability, and In vivo Pharmacodynamics.
Zhang L; Li Y; Wei F; Liu H; Wang Y; Zhao W; Dong Z; Ma T; Wang Q
AAPS PharmSciTech; 2020 Nov; 22(1):1. PubMed ID: 33215299
[TBL] [Abstract][Full Text] [Related]
10. Dissolvable microneedle fabrication using piezoelectric dispensing technology.
Allen EA; O'Mahony C; Cronin M; O'Mahony T; Moore AC; Crean AM
Int J Pharm; 2016 Mar; 500(1-2):1-10. PubMed ID: 26721722
[TBL] [Abstract][Full Text] [Related]
11. Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity.
Budimir N; Huckriede A; Meijerhof T; Boon L; Gostick E; Price DA; Wilschut J; de Haan A
PLoS One; 2012; 7(1):e30898. PubMed ID: 22303469
[TBL] [Abstract][Full Text] [Related]
12. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
[TBL] [Abstract][Full Text] [Related]
13. Heterosubtypic cross-protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration.
Budimir N; de Haan A; Meijerhof T; Gostick E; Price DA; Huckriede A; Wilschut J
Influenza Other Respir Viruses; 2013 Nov; 7(6):1202-9. PubMed ID: 24102979
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches.
Chu LY; Ye L; Dong K; Compans RW; Yang C; Prausnitz MR
Pharm Res; 2016 Apr; 33(4):868-78. PubMed ID: 26620313
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical and immunological characterization of N,N,N-trimethyl chitosan-coated whole inactivated influenza virus vaccine for intranasal administration.
Hagenaars N; Mastrobattista E; Verheul RJ; Mooren I; Glansbeek HL; Heldens JG; van den Bosch H; Jiskoot W
Pharm Res; 2009 Jun; 26(6):1353-64. PubMed ID: 19224344
[TBL] [Abstract][Full Text] [Related]
16. Critical role of TLR7 signaling in the priming of cross-protective cytotoxic T lymphocyte responses by a whole inactivated influenza virus vaccine.
Budimir N; de Haan A; Meijerhof T; Waijer S; Boon L; Gostick E; Price DA; Wilschut J; Huckriede A
PLoS One; 2013; 8(5):e63163. PubMed ID: 23658804
[TBL] [Abstract][Full Text] [Related]
17. Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.
Bungener L; Geeraedts F; Ter Veer W; Medema J; Wilschut J; Huckriede A
Vaccine; 2008 May; 26(19):2350-9. PubMed ID: 18400340
[TBL] [Abstract][Full Text] [Related]
18. Probiotic Lactobacilli Enhance Immunogenicity of an Inactivated H9N2 Influenza Virus Vaccine in Chickens.
Alqazlan N; Astill J; Taha-Abdelaziz K; Nagy É; Bridle B; Sharif S
Viral Immunol; 2021 Mar; 34(2):86-95. PubMed ID: 33236974
[TBL] [Abstract][Full Text] [Related]
19. Effect of viral membrane fusion activity on antibody induction by influenza H5N1 whole inactivated virus vaccine.
Geeraedts F; ter Veer W; Wilschut J; Huckriede A; de Haan A
Vaccine; 2012 Oct; 30(45):6501-7. PubMed ID: 22841974
[TBL] [Abstract][Full Text] [Related]
20. Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin.
Quan FS; Kim YC; Yoo DG; Compans RW; Prausnitz MR; Kang SM
PLoS One; 2009 Sep; 4(9):e7152. PubMed ID: 19779615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
